Carboxypeptidase M Expressed by Human Bone Marrow Cells Cleaves the C-Terminal Lysine of Stromal Cell-Derived Factor-1α: Another Player in Hematopoietic Stem/Progenitor Cell Mobilization?

Feb 23, 2008Stem cells (Dayton, Ohio)

Bone marrow cells produce carboxypeptidase M that trims stromal cell factor-1alpha, possibly affecting stem cell movement

AI simplified

Abstract

CPM transcript is expressed by various hematopoietic and stromal cells, including bone marrow and mobilized peripheral blood CD34(+) cells.

  • Granulocyte-colony-stimulating factor (G-CSF) significantly increases CPM expression at both gene and protein levels in mononuclear and polymorphonuclear cells.
  • Recombinant CPM rapidly cleaves full-length SDF-1alpha, removing its C-terminal lysine and producing des-lys SDF-1alpha.
  • Treatment with CPM reduces the in vitro chemotaxis of hematopoietic stem/progenitor cells (HSPC).
  • The reduced chemotaxis effect is preserved when CPM is treated with the carboxypeptidase inhibitor dl-2-mercaptomethyl-3-guanidino-ethylthiopropanoic acid.
  • Cleavage of SDF-1alpha by CPM may attenuate chemotactic responses and could aid in G-CSF-induced mobilization of HSPC from bone marrow.

AI simplified

Full Text

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free